Albert Brennauer

Title: Overview of Inventor Albert Brennauer and His Patent Contributions

Introduction: Albert Brennauer is an accomplished inventor based in Biberach, Germany, recognized for his innovative work in the field of pharmaceuticals. He holds a significant patent related to NPY2 receptor agonists, reflecting his expertise in biochemistry and medicinal compounds.

Latest Patents: Albert Brennauer holds one notable patent for NPY2 receptor agonists. This invention pertains to PYY analogues that feature alanine at position 4, lysine at position 7, and QRY as the C-terminal end. Furthermore, these analogues are designed with a half-life extending group and exhibit solubility around pH 6 and 7. The patent also encompasses pharmaceutical compositions that include such PYY analogues, along with their medical applications, thereby providing valuable insights into potential therapeutic uses for these compounds.

Career Highlights: Brennauer is currently associated with Boehringer Ingelheim International GmbH, a globally recognized leader in the pharmaceutical industry. His work at this esteemed company has allowed him to push the boundaries of pharmaceutical innovation, contributing to the advancement of treatments in healthcare.

Collaborations: Throughout his career, Albert Brennauer has collaborated with other notable professionals in the field. His coworkers include Peter Wilhelm Haebel and Charlotte Stahl Madsen, both of whom contribute valuable expertise and insight to their joint projects in the pharmaceutical realm.

Conclusion: Albert Brennauer's contributions to the field of pharmaceuticals, especially with his patent on NPY2 receptor agonists, demonstrate the vital role that inventors play in advancing medical science. His work not only represents individual innovation but also showcases the collaborative efforts that drive progress in healthcare solutions.